Pfizer-BioNTech Begins Clinical Trial of Omicron-Targeted Vaccine It's still unclear whether an Omicron-specific vaccine is needed. By Sissi Cao
Big Pharma CEOs Profited Millions From COVID-19 Vaccines—Except For One BioNTech founder Uğur Şahin hasn't sold one company share since February 2020. By Sissi Cao
A Cancer Vaccine Is In Development By COVID-19 Vaccine Maker, Using The Same Tech In principle, mRNA can be applied for many immune system-related illnesses. By Sissi Cao